Tolna Vármegyei Balassa János Kórház
- Address
- lock Available on a paid plan
Tolna Vármegyei Balassa János Kórház - Breast Cancer Research Center
Tolna Vármegyei Balassa János Kórház is a distinguished clinical research center specializing in breast cancer therapeutics. The institution demonstrates significant expertise in conducting multinational clinical trials focusing on both early-stage and advanced breast cancer treatment strategies, with particular emphasis on novel therapeutic approaches and treatment optimization.
- HER2-negative breast cancer treatment including recurrent and metastatic disease
- ER-positive/HER2-negative early breast cancer adjuvant therapy
- Innovative drug delivery systems and oral chemotherapy formulations
The center's research portfolio encompasses investigations of next-generation endocrine therapies and alternative drug delivery methods, including comparative studies of oral versus intravenous paclitaxel formulations. Their participation in extended adjuvant therapy trials, such as those evaluating camizestrant for preventing breast cancer recurrence, underscores their commitment to improving long-term outcomes for patients with hormone receptor-positive breast cancer. This focus on both curative and palliative treatment strategies positions the hospital as an important contributor to advancing breast cancer care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 5 therapeutic areas and 15 of 116 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 114 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 15 by active trials.
- 1AstraZeneca AB6active
lock +14 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB14trials
lock +11 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Tolna Vármegyei Balassa János Kórház
lock Showing 1 of 56 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| (20321) An open-label, single arm, roll-over study to provide continued treatment with darolutamide in participants who were enrolled in previous Bayer sponsored studies | Bayer Consumer Care AG | Phase III | Not Recruiting | Oct 2020 | — |
IMP list
lock Showing 1 of 116 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 9 | Unknown | 2023-01-05 | 2025-04-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.